Public Policy Resources

Share

As a recognized expert in cancer health policy, ACS CAN develops reports, white papers, testimony, fact sheets, regulatory comment letters and public policy on a wide range of issues related to preventing cancer and improving the health care system for persons with cancer and survivors.  We encourage you to use this resource to learn more about our issue priorities and policy work. If you can't find something you need, you may contact us by using our contact form and selecting Policy Resources from the drop-down menu.

Search for Resources

FILTER BY:

Photo of female cancer patient

Patient Quality of Life

ACS CAN advocates for policies that improve the lives of cancer patients by making treatment of their pain and other symptoms and coordination of their care standard protocol throughout their treatment for cancer, starting at the point of diagnosis.
 

Featured Resources

 

The Pain & Policy Studies Group (PPSG) at the University of Wisconsin, the American Cancer Society and the American Cancer Society Cancer Action Network (ACS CAN) have released a report grading states on their enactment of balanced policies to enhance the delivery of effective pain management

This scorecard evaluates balance between needed access to pain medication for cancer patients and efforts to reduce misuse and abuse of pain medications.

Our brochure helps educate cancer patients and their caregivers about palliative care and its benefits. From where you can find it to how you receive it, the brochure can help cancer patients access this important level of medical care.

Photo of ACS CAN Volunteers at Advocacy Event to Support Cancer Research Funding

Research, Funding and Drug Development

Improvements in outcomes for cancer patients require continued research and innovation.  ACS CAN advocates for robust federal funding for cancer research, as well as research and drug approval policies that accelerate the development of new treatments while still ensuring patient safety.

The costs of conducting cancer research include a variety of specific items ranging from researcher salaries, to laboratory supplies, along with utilities and maintenance. 

ACS CAN along with over 80 other patient organizations provided support and feedback to FDA regarding the creation of an Office of Patient Affairs that would help coordinate patient invovlement at FDA.

Expanded access inovolves accessing unapproved therapies outside of clinical trials.  This process has been in existience since the late 1980s, and currently there have been calls to change the process.

Photo of ACS CAN Volunteers participating in health care reform Lobby Day event

Access to Health Care

ACS CAN advocates for policies that provide access to treatments and services people with cancer need for their care - including those who may be newly diagnosed, in active treatment and cancer survivors.

Section 1332 of the Affordable Care Act (ACA) allows states to apply for waivers to experiment with different ways of providing and paying for health care.  These waivers are often referred to as “Section 1332 waivers,” or “state innovation waivers.”  It is important for the cancer community to fully understand how Section 1332 waivers could impact cancer patients and survivors

Congressional efforts to repeal and replace the Affordable Care Act have included additional funding in an effort to stabilize state individual insurance markets.  The funding level proposed is inadequate, as discussed in more detail in this backgrounder.

A Section 1115 Demonstration Waiver gives states flexibility to design and improve upon their Medicaid programs through pilot or demonstration projects.

Photo of Making Strides Against Breast Cancer Event Participant

Prevention and Early Detection

ACS CAN advocates for public policies that can prevent nearly half of all cancer deaths by ensuring access to recommended cancer screenings, protecting the public from skin cancer risk, reducing tobacco use and exposure to secondhand smoke and supporting people in increasing physical activity, eating a healthy diet, and managing their weight.

Testimony Submitted to the House Committee on Appropriations, Subcommittee on State, Foreign Operations, and Related Programs, For Fiscal Year 2018 in support of a proposed statutory proviso that would encourage the Department of State and the U.S. Agency for International Development (USAID) to take steps toward eliminating cervical cancer deaths worldwide.

ACS CAN provided comments in response to a U.S. Food and Drug Administration (FDA) request for information on the use of the term “healthy” on food labels.

ACS CAN supports updating the criteria for "healthy" to be consistent with current research and dietary guidance.  If defined appropriately, “healthy” can be a tool to help consumers identify choices that support long-term health, including reduced cancer risk. 

This factsheet discusses risk factors for breast cancer and the importance of screening in the US.